Programme 2019

Wednesday 23rd January 2019

Moderator: Hans Eiskjaer

(20 min talk and 10 min discussion)

16.00–16.30

Risk Stratification in Pulmonary Arterial Hypertension - Validation of ESC:ERS:s guidelines on treatment follow-up utilizing the Swedish PAH Register

Göran Radegran
Lund, Sweden

16.30–17.00

Lung transplantation in a developing country: perspectives compared with Europe

Pekka Hammainen
Riyadh

17.00–17.30

Coffee break

17.30–18.00

Hepatitis C the beginning of the end; is it really all over?

Barbara Hasse
Zurich, Switzerland

18.00–19.00

Fascinating Failures and Surprising Successes-Case -
6 Case presentation sections (8 mins. Talk - 2 mins. Questions)

18.00–18.10
Azole resistant aspergillosis in lung transplantatione

Breda Lynch
Dublin, Ireland

18.10–18.20
Mystery Papworth Case?!

Caroline Patterson,
Cambridge, UK

18.20–18.30
A sensational success that turned into a complete failure

Stephan Schueler,
Newcastle, UK

18.30–18.40
TBC

Tom Hoel,
Oslo, Norway

18.40–18.50
Sequential HM3 in Borderline Biventricular failure as Bridge to Transplantation

Ronny Gustavsson
Lund, Sweden

18.50–19.00
Beware of the Nanny?

Tji Gan,
Groeningen, Netherlands

Thursday 24th January 2019

Moderator: Clive Lewis + one young investigator

(20 min talk and 10 min discussion)

16.00–16.30

Ventilation strategies on EVLP

Niels van der Kaaij
Utrecht, Netherlands

16.30–17.00

Predicting and preventing primary graft dysfunction in lung transplantation

Jason Christie
Philadelphia, USA

17.00–17.30

Coffee break and business meeting

17.30–18.00

How far away from clinical xenotransplantation are we?

Paolo Brenner
Munich, Germany

18.00–18.30

Transplantation of heart donors with poor cardiac function should be current practice?

Jonatan Oras,
Gothenburg, Sweden

18.30–19.00

WERNER ZUBER MEMORIAL LECTURE

18.00–18.30
Maximize the data, minimise the fraud:
A plea to change the way we publish

Martin Elliott,
London, UK

Friday 25th January 2019

Moderator: Göran Dellgren + one young investigator

(20 min talk and 10 min discussion)

16.00–16.30

Heart failure and transplantation for adults with congenital heart disease.

Clive Lewis
Cambridge, UK

16.30–17.00

Felodipine Reduces Decline in GFR in Lung Transplanted Patients Treated with Cyclosporine: a Randomized Placebo Controlled Trial

Michael Perch
Copenhagen, Denmark

17.00–17.30

Coffee break

(15 min talks and 5 min rebuttal)

17.30–18.00

Pro-Con Debate -
Forget LVAD - ECMO is the way to bridge children to heart transplantation

Pro Martin Elliott, London
versus
Con Oliver Miera, Berlin

18.00–19.30

Young investigators (10 mins. Talk - 5 mins. Questions)

18.00–18.15
Early detection of CAV using highly automated 3-D optical coherence tomography analyses in HTx

Michal Pazdenik
Prague, CZ

18.15–18.30
Comparison of two strategies for EVLP - experimental study in pigs

Tobias Nilsson
Gothenburg, SWE

18.30–18.45
Pushing the frontier with DCD HTx

Simon Messer
Cambridge, UK

18.45–19.00
Platelet aggregation and Cardiac Allograft Vasculopathy in Heart Transplant Recipient

Kamilla Bjerre
Aarhus, DK

19.00–19.15
New onset Diabetes Mellitus after heart transplantation

Lavanya Saiva
Dublin, Ireland

19.15–19.30
Results of bilateral lung transplantation after graft size adjustment

Achim Koch
Essen, Germany